APOBEC3G genetic variants and their influence on the progression to AIDS

Journal of Virology

Volumn 78, Issue 20, 2004, Pages 11070-11076

  An, Ping ^a   Bleiber, Gabriela ⁱ   Duggal, Priya ^c   Nelson, George ^a   May, Margaret ^l   Mangeat, Bastien ^j   Alobwede, Irene ^k   Trono, Didier ^j   Vlahov, David ^d   Donfield, Sharyne ^f   Goedert, James J ^e   Phair, John ^g   Buchbinder, Susan ^h   O'Brien, Stephen J ^b   Telenti, Amalio ⁱ   Winkler, Cheryl A ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f RHO INC   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h S Francisco Dept of Public Health   (United States)

ⁱ UNIVERSITY OF LAUSANNE   (Switzerland)

^j UNIVERSITY OF GENEVA   (Switzerland)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ALLELE; ANTIVIRAL ACTIVITY; ARTICLE; CODON; COHORT ANALYSIS; DISEASE COURSE; DNA POLYMORPHISM; DNA STRAND; EUROPEAN AMERICAN; EXON; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRON; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS REPLICATION; VIRUS TRANSMISSION;

AFRICAN CONTINENTAL ANCESTRY GROUP; CELL LINE; COHORT STUDIES; DISEASE PROGRESSION; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HIV INFECTIONS; HIV-1; HUMANS; NUCLEOSIDE DEAMINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; REPRESSOR PROTEINS; UNITED STATES; VARIATION (GENETICS);

EID: 4644223956     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.20.11070-11076.2004     Document Type: Article

References (33)

1. An, P., G. W. Nelson, L. Wang, S. Donfield, J. J. Goedert, J. Phair, D. Vlahov, S. Buchbinder, W. L. Farrar, W. Modi, S. J. O'Brien, and C. A. Winkler. 2002. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl. Acad. Sci. USA 99:10002-10007.
2. + T cell depletion in human immunodeficiency virus-1-infected individuals. J. Infect. Dis. 188:228-231.
3. Bleiber, G., M. May, C. Suarez, R. Martinez, C. Marzolini, M. Egger, and A. Telenti. 2004. MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment. J. Infect. Dis. 189:583-586.
4. Buchbinder, S. P., M. H. Katz, N. A. Hessol, P. M. O'Malley, and S. D. Holmberg. 1994. Long-term HIV-1 infection without immunologic progression. AIDS 8:1123-1128.
5. Celentano, D. D., N. Galai, A. K. Sethi, N. G. Shah, S. A. Strathdee, D. Vlahov, and J. E. Gallant. 2001. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 15:1707-1715.
6. Centers for Disease Control. 1987. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. Morb. Mortal. Wkly. Rep. 36(Suppl. 1):1S-15S.
7. Centers for Disease Control and Prevention. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mortal. Wkly. Rep. 41:1-19.
8. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856-1862.
9. + T lymphocytes. J. Virol. 66:6489-6495.
10. Gao, X., G. W. Nelson, P. Karacki, M. P. Martin, J. Phair, R. Kaslow, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, S. J. O'Brien, and M. Carrington. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344:1668-1675.
11. Goedert, J. J., C. M. Kessler, L. M. Aledort, R. J. Biggar, W. A. Andes, G. C. White II, J. E. Drummond, K. Vaidya, D. L. Mann, M. E. Eyster, et al. 1989. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N. Engl. J. Med. 321:1141-1148.
12. Goldrick, M. M., G. R. Kimball, Q. Liu, L. A. Martin, S. S. Sommer, and J. Y. Tseng. 1996. NIRCA: a rapid robust method for screening for unknown point mutations. BioTechniques 21:106-112.
13. Harris, R. S., K. N. Bishop, A. M. Sheehy, H. M. Craig, S. K. Petersen-Mahrt, I. N. Watt, M. S. Neuberger, and M. H. Malim. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809.
14. Hilgartner, M. W., S. M. Donfield, A. Willoughby, C. F. Contant, Jr., B. L. Evatt, E. D. Gomperts, W. K. Hoots, J. Jason, K. A. Loveland, S. M. McKinlay, et al. 1993. Hemophilia growth and development study. Design, methods, and entry data. Am. J. Pediatr. Hematol. Oncol. 15:208-218.
15. Jarmuz, A., A. Chester, J. Bayliss, J. Gisbourne, I. Dunham, J. Scott, and N. Navaratnam. 2002. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79:285-296.
16. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Munoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D. L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-411.
17. Lecossier, D., F. Bouchonnet, F. Clavel, and A. J. Hance. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112.
18. Lewontin, R. C. 1964. The interaction of selection and linkage. II. Optimum models. Genetics 50:757-782.
19. Long, J. C., R. C. Williams, and M. Urbanek. 1995. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am. J. Hum. Genet. 56:799-810.
20. MacGinnitie, A. J., S. Anant, and N. O. Davidson. 1995. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J. Biol. Chem. 270:14768-14775.
21. Mangeat, B., P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
22. Mariani, R., D. Chen, B. Scbrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N. R. Landau. 2003. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31.
23. Marin, M., K. M. Rose, S. L. Kozak, and D. Rabat. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:1398-1403.
24. Martin, M. P., M. Dean, M. W. Smith, C. Winkler, B. Gerrard, N. L. Michael, B. Lee, R. W. Doms, J. Margolick, S. Buchbinder, J. J. Goedert, T. R. O'Brien, M. W. Hilgartner, D. Vlahov, S. J. O'Brien, and M. Carrington. 1998. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282:1907-1911.
25. O'Brien, S. J., G. W. Nelson, C. A. Winkler, and M. W. Smith. 2000. Polygenic and multifactorial disease gene association in man: lessons from AIDS. Annu. Rev. Genet. 34:563-591.
26. Phair, J., L. Jacobson, R. Detels, C. Rinaldo, A. Saah, L. Schrager, and A. Munoz. 1992. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multi-center AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 5:490-496.
27. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
28. Sheehy, A. M., N. C. Gaddis, and M. H. Malim. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9:1404-1407.
29. Stopak, K., C. de Noronha, W. Yonemoto, and W. C. Greene. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12:591-601.
30. Strebel, K., D. Daugherty, K. Clouse, D. Cohen, T. Folks, and M. A. Martin. 1987. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328:728-730.
31. + cell count. JAMA 279:35-40.
32. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
33. Zhang, H., B. Yang, R. J. Pomerantz, C. Zhang, S. C. Arunachalam, and L. Gao. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98.